Next Article in Journal
Immune Checkpoint Inhibitors in Combination with Radiotherapy as Salvage Treatment for Relapsed/Refractory Classical Hodgkin Lymphoma: A retrospective Analysis in 12 Patients
Previous Article in Journal
BCR/ABL1 Fluorescence In Situ Hybridization Fusion Signals on Both Copies of Chromosome 22 in a Philadelphia-Masked Chronic Myeloid Leukemia Case: Implication for the Therapy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 13
Issue 2
10.4081/hr.2021.8961
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Successful Use of Phlebotomy to Treat Severe Secondary Polycythemia Due to Chronic Lung Disease

by
Jacob Fuqua
*,
Josephine Reece
and
Sarah Sofka
Robert C. Byrd Health Science Center, Department of Medicine, West Virginia University, P.O. Box 9160, Morgantown, WV 26506, USA
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2021, 13(2), 8961; https://doi.org/10.4081/hr.2021.8961
Submission received: 24 September 2020 / Revised: 9 April 2021 / Accepted: 30 April 2021 / Published: 9 June 2021

Abstract

Secondary polycythemia (SP) occurs as a result of increase erythropoietin levels most commonly as a result of tissue hypoxia. Symptoms such as erythromelalgia, pruritis, and bleeding, which are frequently seen in polycythemia vera (PV), do not commonly occur in SP. Phlebotomy is considered one of the mainstays of therapy for PV but is rarely used for treatment of SP due to concern about worsening tissue hypoxia. We present the case of a patient with severe SP due to chronic hypoxic lung disease who presented with erythromelalgia, pruritis, and bleeding and was treated successfully with therapeutic phlebotomy. This case illustrates the importance of considering the use of therapeutic phlebotomy in symptomatic patients with severe SP.
Keywords: polycythemia; phlebotomy; erythrocytosis polycythemia; phlebotomy; erythrocytosis

Share and Cite

MDPI and ACS Style

Fuqua, J.; Reece, J.; Sofka, S. Successful Use of Phlebotomy to Treat Severe Secondary Polycythemia Due to Chronic Lung Disease. Hematol. Rep. 2021, 13, 8961. https://doi.org/10.4081/hr.2021.8961

AMA Style

Fuqua J, Reece J, Sofka S. Successful Use of Phlebotomy to Treat Severe Secondary Polycythemia Due to Chronic Lung Disease. Hematology Reports. 2021; 13(2):8961. https://doi.org/10.4081/hr.2021.8961

Chicago/Turabian Style

Fuqua, Jacob, Josephine Reece, and Sarah Sofka. 2021. "Successful Use of Phlebotomy to Treat Severe Secondary Polycythemia Due to Chronic Lung Disease" Hematology Reports 13, no. 2: 8961. https://doi.org/10.4081/hr.2021.8961

APA Style

Fuqua, J., Reece, J., & Sofka, S. (2021). Successful Use of Phlebotomy to Treat Severe Secondary Polycythemia Due to Chronic Lung Disease. Hematology Reports, 13(2), 8961. https://doi.org/10.4081/hr.2021.8961

Article Metrics

Back to TopTop